- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Climb Bio Inc (CLYM)
Assess today's live Climb Bio Inc (CLYM) share price, performance and insights using our live NASDAQ: CLYM stock exchange data.
Analyse the historical data and Climb Bio Inc share price performance charts on this page. Our technical summary section provides analysis on Climb Bio share price buy/sell indicators using real-time data (or discuss the Climb Bio (CLYM) stock price today with other investors in the Climb Bio NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CLYM share price (ISIN: US28658R1068) to enhance your trading decisions with our free investment tools and resources.
What Is the Climb Bio Inc Share Price Today?
The Climb Bio share price today is 4.600.
What Is the Stock Symbol for Climb Bio Inc
The stock symbol (or 'ticker') for Climb Bio Inc is "CLYM."
What Stock Exchange Does Climb Bio Inc Trade On?
Climb Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Climb Bio Inc a Good Stock to Buy?
Determining whether Climb Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Climb Bio Inc share price performance charts on this page. Our technical summary section provides analysis on Climb Bio share price buy/sell indicators using real-time data (or discuss the Climb Bio (CLYM) stock price today with other investors in the Climb Bio NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ CLYM share price (ISIN: US28658R1068) to enhance your trading decisions with our free investment tools and resources.
What Is the Climb Bio Inc Share Price Today?
The Climb Bio share price today is 4.600.
What Is the Stock Symbol for Climb Bio Inc
The stock symbol (or 'ticker') for Climb Bio Inc is "CLYM."
What Stock Exchange Does Climb Bio Inc Trade On?
Climb Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Climb Bio Inc a Good Stock to Buy?
Determining whether Climb Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.465
5.048
52 wk Range
1.050
5.048
Trading near 52-week High
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.4655.048
52 wk Range
1.0505.048
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CLYM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
9.600
Upside
+108.70%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
- Form 8K Climb Bio Inc For: 6 November
- Investing.com
- Form 8K Climb Bio Inc For: 11 December
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Climb Bio Company Profile
Climb Bio, Inc., a clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases. The company develops budoprutug, an anti-CD19 monoclonal antibody for the treatment of B-cell mediated diseases. It is also developing budoprutug IV for the treatment of primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus. In addition, the company is developing CLYM116, a preclinical stage anti A Proliferation-inducing Ligand (APRIL) monoclonal antibody for the treatment of immunoglobin A nephropathy (IgAN). The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wellesley Hills, Massachusetts.
Compare CLYM to Peers and Sector
Metrics to compare | CLYM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCLYMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.2x | −2.8x | −0.6x | |
PEG Ratio | −0.11 | −0.02 | 0.00 | |
Price/Book | 1.8x | 2.4x | 2.6x | |
Price / LTM Sales | - | 23.4x | 3.2x | |
Upside (Analyst Target) | 104.1% | 100.7% | 41.8% | |
Fair Value Upside | Unlock | 10.7% | 5.1% | Unlock |
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 9.600
(+108.70% Upside)
Earnings
Latest Release
Nov 06, 2025
EPS / Forecast
-0.19 / -0.1467
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Climb Bio (CLYM) Share Price Today?
The live Climb Bio share price today is 4.600
What Stock Exchange Does Climb Bio (CLYM) Trade On?
Climb Bio is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Climb Bio?
The stock symbol (also called a 'ticker') for Climb Bio is "CLYM."
What Is the Current Climb Bio Market Cap?
As of today, Climb Bio market capitalisation is 313.65M.
What Is Climb Bio's (CLYM) Earnings Per Share (TTM)?
The Climb Bio EPS is currently -0.75 (Trailing Twelve Months).
When Is the Next Climb Bio Earnings Date?
Climb Bio's next earnings report will be released on 09 Mar 2026.
Is CLYM a Buy or Sell From a Technical Analyst Perspective?
Based on today's Climb Bio moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Climb Bio Stock Split?
Climb Bio has split 0 times. (See the CLYM stock split history page for full effective split date and price information.)
How Many Employees Does Climb Bio Have?
Climb Bio has 18 employees.
What is the current trading status of Climb Bio (CLYM)?
As of 24 Dec 2025, Climb Bio (CLYM) is trading at a price of 4.600, with a previous close of 4.600. The stock has fluctuated within a day range of 4.465 to 5.048, while its 52-week range spans from 1.050 to 5.048.
What Is Climb Bio (CLYM) Price Target According to Analysts?
The average 12-month price target for Climb Bio is USD9.6, with a high estimate of USD11 and a low estimate of USD8. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +108.70% Upside potential.
What Is the CLYM After Hours Price?
CLYM's last after hours stock price is 4.790, the stock has decreased by 0.190, or 4.130%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.